Back
Dermata Therapeutics, Inc. Stock Price Chart
Gold Is Going Digital-And NatGold May Come After Bitcoin
Reserve NatGold Tokens pre-market-no payment required today.
Sell
22
DRMA
Dermata Therapeutics, Inc.
Last Price:
$1.85
Seasonality Move:
-44.53%
7 Day Trial
ALL ACCESS PASS
$
7
Bitcoin was First. NatGold is the Masterpiece.
Reserve Your Tokens Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing selling pressure, which indicates risk of future bearish movement.
Dermata Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.48 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.44 | Sell |
| 200-day SMA: | 5.13 | Sell |
| 8-day EMA: | 2.37 | Sell |
| 20-day EMA: | 2.35 | Sell |
| 50-day EMA: | 2.6 | Sell |
| 200-day EMA: | 7.67 | Sell |
Dermata Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 44.43 | Sell |
| Chaikin Money Flow: | -496159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.98 - 2.52) | Sell |
| Bollinger Bands (100): | (2.21 - 4.53) | Sell |
Dermata Therapeutics, Inc. Technical Analysis
| Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics, Inc. Stock
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.02 while DRMA 8-day simple moving average is 2.48, which is a Sell signal.
-
The stock price of DRMA is 2.02 while Dermata Therapeutics, Inc. 20-day SMA is 2.28, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day simple moving average is 2.44 while DRMA share price is 2.02, making it a Sell technically.
-
DRMA stock price is 2.02 and Dermata Therapeutics, Inc. 200-day simple moving average is 5.13, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
22
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy or a Sell?
-
Dermata Therapeutics, Inc. stock is rated a SellThe current Dermata Therapeutics, Inc. [DRMA] share price is $2.02. The Score for DRMA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics, Inc. Stock Info
Market Cap:
2.1M
Price in USD:
2.02
Share Volume:
640.1K
Dermata Therapeutics, Inc. 52-Week Range
52-Week High:
23.70
52-Week Low:
1.58
Sell
22
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Dermata Therapeutics, Inc. Share Price Forecast
-
What is the Dermata Therapeutics, Inc. stock price today?The Dermata Therapeutics, Inc. stock price is 2.02 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics, Inc. is overvalued.
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.02 while DRMA 8-day exponential moving average is 2.37, which is a Sell signal.
-
The stock price of DRMA is 2.02 while Dermata Therapeutics, Inc. 20-day EMA is 2.35, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day exponential moving average is 2.60 while DRMA share price is 2.02, making it a Sell technically.
-
DRMA stock price is 2.02 and Dermata Therapeutics, Inc. 200-day simple moving average is 7.67, creating a Sell signal.
Technical Analysis of Dermata Therapeutics, Inc.
Should I short Dermata Therapeutics, Inc. stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Dermata Therapeutics, Inc. is a Sell
-
Dermata Therapeutics, Inc. Relative Strength Index (RSI) is 44.43, which suggest Dermata Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Dermata Therapeutics, Inc. is (1.98 - 2.52), which suggest Dermata Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Dermata Therapeutics, Inc. is (2.21 - 4.53), which suggest Dermata Therapeutics, Inc. is a Sell
* Dermata Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.